These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19633693)
1. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693 [TBL] [Abstract][Full Text] [Related]
2. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625 [TBL] [Abstract][Full Text] [Related]
3. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Rao SN; Rao RD Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659 [TBL] [Abstract][Full Text] [Related]
5. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease. Kurt RA; Yalçindag N; Atilla H; Arat M Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049 [TBL] [Abstract][Full Text] [Related]
6. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Ogawa Y; Yamazaki K; Kuwana M; Mashima Y; Nakamura Y; Ishida S; Toda I; Oguchi Y; Tsubota K; Okamoto S; Kawakami Y Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):111-9. PubMed ID: 11133855 [TBL] [Abstract][Full Text] [Related]
7. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Wang Y; Ogawa Y; Dogru M; Tatematsu Y; Uchino M; Kamoi M; Okada N; Okamoto S; Tsubota K Bone Marrow Transplant; 2010 Jun; 45(6):1077-83. PubMed ID: 19898506 [TBL] [Abstract][Full Text] [Related]
8. [Dry eye in graft-versus-host disease]. Fei WL; Chen JQ; Du X; Liu YH; Sun MX; Lin JX; Weng JY; Luo TZ; Yin DM; Luo XY Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066 [TBL] [Abstract][Full Text] [Related]
9. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Toker E; Asfuroğlu E Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Chiang CC; Lin JM; Chen WL; Tsai YY Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. Salib GM; McDonald MB; Smolek M J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Kamoi M; Ogawa Y; Dogru M; Uchino M; Kawashima M; Goto E; Mori T; Okamoto S; Shimazaki J; Tsubota K Curr Eye Res; 2007 Oct; 32(10):837-42. PubMed ID: 17963103 [TBL] [Abstract][Full Text] [Related]
13. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Wilson SE; Perry HD Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588 [TBL] [Abstract][Full Text] [Related]
15. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome]. Kujawa A; Rózycki R Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939 [TBL] [Abstract][Full Text] [Related]
16. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Russo PA; Bouchard CS; Galasso JM Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749 [TBL] [Abstract][Full Text] [Related]
17. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969 [TBL] [Abstract][Full Text] [Related]
18. Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease. Ban Y; Ogawa Y; Goto E; Uchino M; Terauchi N; Seki M; Nakaya M; Saiki M; Mori T; Okamoto S; Matsumoto Y; Dogru M; Shimazaki J; Tsubota K Eye (Lond); 2009 Jan; 23(1):202-8. PubMed ID: 19011604 [TBL] [Abstract][Full Text] [Related]
19. Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination. Sáles CS; Johnston LJ; Ta CN Cornea; 2011 Feb; 30(2):143-9. PubMed ID: 20885310 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Yoon KC; Jeong IY; Im SK; Park YG; Kim HJ; Choi J Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]